Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.32 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | MITF | O75030 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | CCR6 | P51684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7638 | 0.85 | ALDH1A1 (0.63) | ALDH1A1TSHRMEN1KMT2ALMNA | |
| SCHEMBL473080 | 0.85 | ALDH1A1 (0.63) | ALDH1A1TSHRMEN1KMT2ALMNA | |
| SCHEMBL29405187 | 0.85 | ALDH1A1 (0.63) | ALDH1A1TSHRMEN1KMT2ALMNA | |
| SCHEMBL9713659 | 0.85 | MEN1 (0.44) | ALDH1A1TSHRMEN1KMT2ALMNA | |
| SCHEMBL1176773 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TSHRMEN1KMT2ALMNA | |
| SCHEMBL11016199 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TSHRMEN1KMT2ALMNA | |
| SCHEMBL8719955 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TSHRMEN1KMT2ALMNA | |
| SCHEMBL22496001 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TSHRMEN1KMT2ALMNA | |
| SCHEMBL9562250 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TSHRMEN1KMT2ALMNA | |
| Water SCHEMBL20379011 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TSHRMEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217677-A1 | Organic Electronic Device Comprising a Substrate, an Anode Layer, a Cathode Layer, at Least One First Emission Layer, and a Hole Injection Layer That Comprises a Metal Complex | NOVALED GMBH (DE) | 2023-07-06 | — | — | US | disclosed |
| US-20230010535-A1 | ELECTROACTIVE COMPOUNDS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2023-01-12 | — | — | US | disclosed |
| US-10858610-B2 | Cold cranking simulator viscosity boosting base stocks and lubricating oil formulations containing the same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-12-08 | — | — | US | disclosed |
| US-20200172675-A1 | LOW-COLOR POLYMERS FOR FLEXIBLE SUBSTRATES IN ELECTRONIC DEVICES | DUPONT ELECTRONICS, INC. | 2020-06-04 | — | — | US | disclosed |
| US-20020082357-A1 | Resin and its use in converting morphine to codeine | CORCORAN ROBERT C (US) | 2002-06-27 | — | — | US | disclosed |
| WO-2002028917-A2 | RESIN AND ITS USE IN CONVERTING MORPHINE TO CODEINE | CORCORAN ROBERT C (US) | 2002-04-11 | — | — | WO | disclosed |
| EP-0516257-B1 | Phenylbenzo[b]furans and -thiophenes, procedures for their preparation, and pharmaceutical compositions containing the same | SCHERING AG (DE) | 1998-08-05 | — | — | EP | disclosed |
| US-5470854-A | Antiestrogens | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-11-28 | — | — | US | disclosed |
| WO-1992021669-A1 | 2-PHENYLBENZO[B]FURANS AND THIOPHENES, METHODS OF PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-12-10 | — | — | WO | disclosed |
| EP-0516257-A1 | Phenylbenzo[b]furans and -thiophenes, procedures for their preparation, and pharmaceutical compositions containing the same | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020082357-A1 | Resin and its use in converting morphine to codeine | OPRM1, OPRK1, OPRL1 | ALDH1A1 1395/4885TSHR 3710/4885MEN1 4170/4885 |
| US-20230010535-A1 | ELECTROACTIVE COMPOUNDS | NR4A2, NR2C2, ESR2 | ALDH1A1 3088/4885TSHR 1089/4885MEN1 1209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.